Cover Image
Market Research Report

Europe Spirometer Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Published by Data Bridge Market Research Private Limited Product code 590843
Published Content info 350 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Spirometer Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
Published: November 1, 2017 Content info: 350 Pages
Description

The Europe Spirometer Market is expected to reach USD 349.25 million by 2024, from USD 177.79 million in 2016 growing at a CAGR of 8.9% in the forecast period 2017 to 2024.

The major factors driving the growth of this market are increasing prevalence of respiratory diseases, increased demand of homecare setting devices, and rise in the number of smokers.

The key market players for Europe Spirometer Market are listed below:

BD,

Midmark Corp

Welch allyn

SDI Diagnostics,

Geratherm Respiratory GMBH,

The market is further segmented into:

Type

Application

End User

Geography

The Europe spirometer market is segmented on the basis of product type, technology, disease, disposable components, application, end-user and distribution channel. On the basis of product type, the Europe spirometer market is segmented into table-top spirometer, hand-held spirometer and pc based spirometer.

Based on technology, the Europe spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter. In 2017, flow measurement spirometer is expected to dominate the Europe spirometer market with 68.4% market share and is expected to reach USD 244.9 million by 2024, growing at a CAGR of 9.3% in the forecast period 2017 to 2024.

Based on, the Europe spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer, and others. In 2017, chronic obstructive lung disease is expected to dominate the Europe spirometer market with 42.7% market share and is expected to reach USD 154.0 million by 2024, growing with the highest CAGR of 9.4% in the forecast period 2017 to 2024.

Based on disposable components, the Europe spirometer market is segmented into filters, tubes and sensors. In 2017, filters is expected to dominate the Europe spirometer market with 75.0% market share and is expected to reach USD 265.4 million by 2024, growing with the highest CAGR of 9.1% in the forecast period 2017 to 2024.

Based on application, the Europe spirometer market is segmented into diagnostics and therapeutics. In 2017, diagnostics is expected to dominate the Europe spirometer market with 65.8% market share and is expected to reach USD 238.1 million by 2024, growing with the highest CAGR of 9.5% in the forecast period 2017 to 2024.

Based on end-user, the Europe spirometer market is segmented into hospitals, clinics and homecare. In 2017, hospitals is expected to dominate the Europe spirometer market with 51.0% market share and is expected to reach USD 183.7 million by 2024, growing at a CAGR of 9.4% in the forecast period 2017 to 2024.

Based on distribution channel, the Europe spirometer market is segmented into direct tender and over the counter. In 2017, direct tender is expected to dominate the Europe spirometer market with 65.1% market share and is expected to reach USD 232.3 million by 2024, growing at a CAGR of 9.3% in the forecast period 2017 to 2024.

Based on geography, the Europe Spirometer market is segmented into 11 geographical regions, such as,

Germany,

France,

United Kingdom,

Italy,

Spain,

Russia,

Turkey,

Belgium,

Netherlands,

Switzerland,

Rest of Europe

Covered in this report

The report covers the present scenario and the growth prospects of the Europe Spirometer market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

TABLE OF CONTENTS

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OVERVIEW OF THE EUROPE SPIROMETER MARKET
  • 1.2. CURRENCY AND PRICING
  • 1.3. LIMITATION
  • 1.4. MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1. KEY TAKEAWAYS
  • 2.2. ARRIVING AT THE EUROPE SPIROMETER MARKET SIZE
    • 2.2.1 VENDOR POSITIONING GRID
    • 2.2.2 TECHNOLOGY LIFE LINE CURVE
    • 2.2.3 MARKET TIME LINE
    • 2.2.4 MARKET GUIDE
    • 2.2.5 COMPANY POSITIONING GRID
    • 2.2.6 COMAPANY MARKET SHARE ANALYSIS
    • 2.2.7 MULTIVARIATE MODELLING
    • 2.2.8 STANDARDS OF MEASUREMENT
    • 2.2.9 TOP TO BOTTOM ANALYSIS
    • 2.2.10 VENDOR SHARE ANALYSIS
    • 2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
    • 2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
  • 2.3. EUROPE SPIROMETER MARKET: RESEARCH SNAPSHOT
  • 2.4. ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1. DRIVERS
    • 3.1.1. RISING INCIDENCE OF RESPIRATORY DISEASES
    • 3.1.2. TECHNOLOGICAL ADVANCEMENTS IN RESPIRATORY DEVICES
    • 3.1.3. INCREASED DEMAND OF HOMECARE SETTING DEVICES
  • 3.2. RESTRAINTS
    • 3.2.1. WEAK REIMBURSEMENT POLICIES
  • 3.3. OPPORTUNITIES
    • 3.3.1. TECHNOLOGY DRIVING THE MARKET PROVIDES OPPURTUNITY TO UPCOMING PLAYERS
    • 3.3.2. GOVERNMENT INITIATIVES TO CREATE AWARNESS REGARDING RESPIRATORY DISEASES AND ITS TREATMENT
  • 3.4. CHALLENGES
    • 3.4.1. LACK OF TRAINED PROFESSIONALS FOR SUPERVISING HIGH QUALITY SPIROMETERS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

  • 5.1. EPIDEMIOLOGY STATISTICS OF CHRONIC OBSTRUCTIVE

LUNG DISEASE

  • 5.2. POPULATION DATA STATISTICS OF DIFFERENT TYPES OF RESPIRATORY DISEASES
  • 5.3. VENDOR POSITIONING GRID AND INVESTMENT OPPURTUNITIES
  • 5.4. TECHNOLOLGICAL ADVANCEMENTS
  • 5.5. REIMBURSEMENT RATES
  • 5.6. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE EUROPE SPIROMETER MARKET
  • 5.7. MARKET REGULATORY SCENARIO
  • 5.8. INTERVIEW KEY INSIGHTS

6 EUROPE SPIROMETER MARKET, BY PRODUCT TYPE

  • 6.1. OVERVIEW
  • 6.2. TABLE-TOP SPIROMETER
  • 6.3. HAND-HELD SPIROMETER
  • 6.4. DESKTOP SPIROMETER

7 EUROPE SPIROMETER MARKET, BY TECHNOLOGY

  • 7.1. OVERVIEW
  • 7.2. VOLUME MEASUREMENT SPIROMETER
    • 7.2.1 WET SPIROMETERS
    • 7.2.2. DRY SPIROMETERS
  • 7.3. FLOW MEASUREMENT SPIROMETER
    • 7.3.1 PNEUMO-TACHOGRAPH SYSTEMS
    • 7.3.2. MASS FLOW METERS
  • 7.4. PEAK FLOW METER
  • 7.5. OTHERS

8 EUROPE SPIROMETER MARKET, BY DISEASE

  • 8.1. OVERVIEW
  • 8.2. ASTHMA
  • 8.3. BRONCHITIS
  • 8.4. EMPHYSEMA
  • 8.5. CHRONIC OBSTRUCTIVE LUNG DISEASE
  • 8.6. LUNG CANCER
  • 8.7. OTHERS

9 EUROPE SPIROMETER MARKET, BY DISPOSABLE COMPONENTS

  • 9.1. OVERVIEW
  • 9.2. FILTERS
  • 9.3. SENSORS
  • 9.4. TUBES

10 EUROPE SPIROMETER MARKET, BY APPLICATION

  • 10.1. OVERVIEW
  • 10.2. DIAGNOSTICS
  • 10.3. THERAPEUTIC

11 EUROPE SPIROMETER MARKET, BY END-USER

  • 11.1. OVERVIEW
  • 11.2. HOSPITALS
  • 11.3. CLINICS
  • 11.4. HOMECARE

12 EUROPE SPIROMETER MARKET, BY DISTRIBUTION CHANNEL

  • 12.1. OVERVIEW
  • 12.2. OVER THE COUNTER
  • 12.3. DIRECT TENDER

13 EUROPE SPIROMETER MARKET: COMPETITIVE LANDSCAPE

  • 13.1. EUROPE SPIROMETER MARKET: COMPANY SHARE ANALYSIS
  • 13.2. MERGERS & ACQUISITIONS
  • 13.3. NEW PRODUCT DEVELOPMENT & APPROVALS
  • 13.4. EXPANSIONS
  • 13.5. REGULATORY CHANGES
  • 13.6. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

14 EUROPE SPIROMETER MARKET, COMPANY PROFILES

  • 14.1 WELCH ALLYN
    • 14.1.1 COMPANY OVERVIEW
    • 14.1.2. FINANCIAL ANALYSIS
    • 14.1.3. PRODUCT MATRIX
    • 14.1.4 RECENT DEVELOPMENTS
    • 14.1.5. DATABRIDGE ANALYSIS

  • 14.2 MIDMARK CORP.
    • 14.2.1. COMPANY OVERVIEW
    • 14.2.2 FINANCIAL ANALYSIS
    • 14.2.3 PRODUCT MATRIX
    • 14.2.4. RECENT DEVELOPMENTS
    • 14.2.5. DATABRIDGE ANALYSIS
  • 14.3 FUTUREMED
    • 14.3.1. COMPANY OVERVIEW
    • 14.3.2. FINANCIAL ANALYSIS
    • 14.3.3. PRODUCT MATRIX
    • 14.3.4. RECENT DEVELOPMENTS
    • 14.3.5. DATABRIDGE ANALYSIS
  • 14.4 COSMED
    • 14.4.1. COMPANY OVERVIEW
    • 14.4.2. FINANCIAL ANALYSIS
    • 14.4.3. PRODUCT MATRIX
    • 14.4.4. RECENT DEVELOPMENTS
    • 14.4.5. DATABRIDGE ANALYSIS
  • 14.5 MGC DIAGNOSTICS CORPORATION
    • 14.5.1. COMPANY OVERVIEW
    • 14.5.2. FINANCIAL ANALYSIS
    • 14.5.3. PRODUCT MATRIX
    • 14.5.4. RECENT DEVELOPMENTS
    • 14.5.5. DATABRIDGE ANALYSIS

  • 14.6 NIHON KOHDEN CORPORATION
    • 14.6.1. COMPANY OVERVIEW
    • 14.6.2. FINANCIAL ANALYSIS
    • 14.6.3. PRODUCT MATRIX
    • 14.6.4. RECENT DEVELOPMENTS
    • 14.6.5. DATABRIDGE ANALYSIS
  • 14.7 CHEST M.I., INC
    • 14.7.1. COMPANY OVERVIEW
    • 14.7.2. FINANCIAL ANALYSIS
    • 14.7.3. PRODUCT MATRIX
    • 14.7.4. RECENT DEVELOPMENTS
    • 14.7.5. DATABRIDGE ANALYSIS
  • 14.8 MEDICAL INTERNATIONAL RESEARCH
    • 14.8.1. COMPANY OVERVIEW
    • 14.8.2. FINANCIAL ANALYSIS
    • 14.8.3. PRODUCT MATRIX
    • 14.8.4. RECENT DEVELOPMENTS
    • 14.8.5. DATABRIDGE ANALYSIS
  • 14.9 VITALOGRAPH
    • 14.9.1. COMPANY OVERVIEW
    • 14.9.2. FINANCIAL ANALYSIS
    • 14.9.3. PRODUCT MATRIX
    • 14.9.4. RECENT DEVELOPMENTS
    • 14.9.5. DATABRIDGE ANALYSIS

  • 14.10 NDD MEDIZINTECHNIK AG
    • 14.10.1. COMPANY OVERVIEW
    • 14.10.2. FINANCIAL ANALYSIS
    • 14.10.3. PRODUCT MATRIX
    • 14.10.4. RECENT DEVELOPMENTS
    • 14.10.5. DATABRIDGE ANALYSIS
  • 14.11 SCHILLER
    • 14.11.1. COMPANY OVERVIEW
    • 14.11.2. FINANCIAL ANALYSIS
    • 14.11.3. PRODUCT MATRIX
    • 14.11.4. RECENT DEVELOPMENTS
    • 14.11.5. DATABRIDGE ANALYSIS
  • 14.12 JONES MEDICAL INSTRUMENT COMPANY
    • 14.12.1. COMPANY OVERVIEW
    • 14.12.2. FINANCIAL ANALYSIS
    • 14.12.3. PRODUCT MATRIX
    • 14.12.4. RECENT DEVELOPMENTS
    • 14.12.5. DATABRIDGE ANALYSIS
  • 14.13 SDI DIAGNOSTICS
    • 14.13.1. COMPANY OVERVIEW
    • 14.13.2. FINANCIAL ANALYSIS
    • 14.13.3. PRODUCT MATRIX
    • 14.13.4. RECENT DEVELOPMENTS
    • 14.13.5. DATABRIDGE ANALYSIS

  • 14.14 GERATHERN RESPIRATORY GMBH
    • 14.14.1. COMPANY OVERVIEW
    • 14.14.2. FINANCIAL ANALYSIS
    • 14.14.3. PRODUCT MATRIX
    • 14.14.4. RECENT DEVELOPMENTS
    • 14.14.5. DATABRIDGE ANALYSIS
  • 14.15 THOR
    • 14.15.1. COMPANY OVERVIEW
    • 14.15.2. FINANCIAL ANALYSIS
    • 14.15.3. PRODUCT MATRIX
    • 14.15.4. RECENT DEVELOPMENTS
    • 14.15.5. DATABRIDGE ANALYSIS
  • 14.16 FUKUDA SANGYO INC.
    • 14.16.1. COMPANY OVERVIEW
    • 14.16.2. FINANCIAL ANALYSIS
    • 14.16.3. PRODUCT MATRIX
    • 14.16.4. RECENT DEVELOPMENTS
    • 14.16.5. DATABRIDGE ANALYSIS
  • 14.17 CONTEC MEDICAL SYSTEMS CO., LTD.
    • 14.17.1. COMPANY OVERVIEW
    • 14.17.2. FINANCIAL ANALYSIS
    • 14.17.3. PRODUCT MATRIX
    • 14.17.4. RECENT DEVELOPMENTS
    • 14.17.5. DATABRIDGE ANALYSIS

  • 14.18 KONINKLIJKE PHILIPS N.V.
    • 14.18.1. COMPANY OVERVIEW
    • 14.18.2. FINANCIAL ANALYSIS
    • 14.18.3. PRODUCT MATRIX
    • 14.18.4. RECENT DEVELOPMENTS
    • 14.18.5. DATABRIDGE ANALYSIS
  • 14.19 BD
    • 14.19.1. COMPANY OVERVIEW
    • 14.19.2. FINANCIAL ANALYSIS
    • 14.19.3. PRODUCT MATRIX
    • 14.19.4. RECENT DEVELOPMENTS
    • 14.19.5. DATABRIDGE ANALYSIS
  • 14.20 CARDIOTECH
    • 14.20.1. COMPANY OVERVIEW
    • 14.20.2. FINANCIAL ANALYSIS
    • 14.20.3. PRODUCT MATRIX
    • 14.20.4. RECENT DEVELOPMENTS
    • 14.20.5. DATABRIDGE ANALYSIS

15 APPENDIX

16 ABOUT DATA BRIDGE MARKET RESEARCH

Back to Top